MENU
+Compare
WVE
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$7.14
Change
+$0.15 (+2.15%)
Capitalization
1.19B

WVE Wave Life Sciences Ltd Forecast, Technical & Fundamental Analysis

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health... Show more

Industry: #Biotechnology
WVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for WVE with price predictions
Nov 28, 2025

WVE's Stochastic Oscillator is remaining in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for WVE moved out of overbought territory on November 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The 10-day moving average for WVE crossed bearishly below the 50-day moving average on November 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WVE broke above its upper Bollinger Band on October 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 24, 2025. You may want to consider a long position or call options on WVE as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WVE just turned positive on November 25, 2025. Looking at past instances where WVE's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

WVE moved above its 50-day moving average on November 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WVE advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 164 cases where WVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.588) is normal, around the industry mean (27.312). P/E Ratio (0.000) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (10.718) is also within normal values, averaging (321.020).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
WVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

WVE is expected to report earnings to fall 14.72% to -27 cents per share on March 10

Wave Life Sciences Ltd WVE Stock Earnings Reports
Q4'25
Est.
$-0.27
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.04
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.34
The last earnings report on November 10 showed earnings per share of -31 cents, missing the estimate of -25 cents. With 2.62M shares outstanding, the current market capitalization sits at 1.19B.
A.I. Advisor
published General Information

General Information

a provider of nucleic acid therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Marina One East Tower
Phone
+65 62363388
Employees
268
Web
https://www.wavelifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIUCX18.91N/A
N/A
JPMorgan Developed International Value C
MASPX31.66N/A
N/A
BlackRock Advantage SMID Cap Instl
EMEAX14.57N/A
N/A
Ashmore Emerging Markets Equity A
UBVUX83.97N/A
N/A
Undiscovered Managers Behavioral Val R4
PGKCX29.43N/A
N/A
PGIM Jennison Technology C

WVE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-5.67%
XNCR - WVE
53%
Loosely correlated
-3.15%
SYRE - WVE
52%
Loosely correlated
-0.91%
NRIX - WVE
50%
Loosely correlated
-3.31%
XENE - WVE
49%
Loosely correlated
-1.45%
DSGN - WVE
48%
Loosely correlated
+0.11%
More

Groups containing WVE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-5.67%
WVE
(2 stocks)
98%
Closely correlated
+2.32%